XML 72 R35.htm IDEA: XBRL DOCUMENT
v3.21.2

Segments (Tables) | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jul. 03, 2021 | Dec. 31, 2020
Schedule Of Reconciliation Of Operating Profit (Loss) From Segments To Consolidated | The following table presents segment adjusted EBITDA reconciled to income before income taxes:
|  | Three Months Ended |  |  | Six Months Ended |
|  | July 3, 2021 |  |  | June 27, 2020 |  |  | July 3, 2021 |  |  | June 27, 2020 |
Segment adjusted EBITDA |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  | $ | 17,149 |  |  | $ | 7,439 |  |  | $ | 27,147 |  |  | $ | 21,151 |
International |  |  | 2,738 |  |  |  | (497 | ) |  |  | 3,810 |  |  |  | 37 |
Depreciation and amortization |  |  | (7,479 | ) |  |  | (7,248 | ) |  |  | (14,663 | ) |  |  | (14,513 | )
Interest (expense) income |  |  | (1,681 | ) |  |  | (2,834 | ) |  |  | 1,195 |  |  |  | (5,215 | )
Equity compensation |  |  | (5,853 | ) |  |  | (255 | ) |  |  | 16,559 |  |  |  | 6,771 |
COVID-19 benefits, net |  |  | — |  |  |  | 1,101 |  |  |  | — |  |  |  | 1,101 |
Succession and transition charges |  |  | (187 | ) |  |  | (3,801 | ) |  |  | (344 | ) |  |  | (4,574 | )
Foreign currency impact |  |  | 12 |  |  |  | 46 |  |  |  | 64 |  |  |  | (40 | )
Acquisition and integration costs |  |  | (1,833 | ) |  |  | — |  |  |  | (5,029 | ) |  |  | — |
Inventory step-up costs |  |  | (2,106 | ) |  |  | — |  |  |  | (2,106 | ) |  |  |  |
Equity loss in unconsolidated investments |  |  | (432 | ) |  |  | — |  |  |  | (901 | ) |  |  | — |
Change in fair value of contingent consideration |  |  | (641 | ) |  |  | — |  |  |  | (641 | ) |  |  | — |
Impairments related to variable interest entity |  |  | (7,043 | ) |  |  | — |  |  |  | (7,043 | ) |  |  | — |
Other non-recurring costs |  |  | (1,710 | ) |  |  | (41 | ) |  |  | (2,659 | ) |  |  | (283 | )
(Loss) income before income taxes |  | $ | (9,066 | ) |  | $ | (6,090 | ) |  | $ | 15,389 |  |  | $ | 4,435 |
Bio Ventus LLC |  |
Schedule Of Reconciliation Of Operating Profit (Loss) From Segments To Consolidated |  | The following table presents segment adjusted EBITDA reconciled to income from continuing operations before income taxes for the years ended December 31 as follows:
|  | 2020 |  |  | 2019 |  |  | 2018 |
Segment adjusted EBITDA from continuing operations |  |  |  |  |  |  |  |  |  |  |  |
U.S. |  | $ | 69,252 |  |  | $ | 71,673 |  |  | $ | 67,480 |
International |  |  | 3,191 |  |  |  | 7,515 |  |  |  | 4,691 |
Depreciation and amortization |  |  | (28,643 | ) |  |  | (30,316 | ) |  |  | (29,238 | )
Interest expense |  |  | (9,751 | ) |  |  | (21,579 | ) |  |  | (19,171 | )
Equity compensation |  |  | (10,103 | ) |  |  | (10,844 | ) |  |  | (14,325 | )
COVID-19 benefits, net |  |  | 4,123 |  |  |  | — |  |  |  | — |
Succession and transition charges |  |  | (5,609 | ) |  |  | — |  |  |  | — |
Restructuring costs |  |  | (563 | ) |  |  | (575 | ) |  |  | (1,373 | )
Foreign currency impact |  |  | 117 |  |  |  | (8 | ) |  |  | (234 | )
Equity loss in unconsolidated investments |  |  | (467 | ) |  |  | — |  |  |  | — |
Other non-recurring costs |  |  | (5,633 | ) |  |  | (6,177 | ) |  |  | (1,723 | )
Income from continuing operations before income taxes |  | $ | 15,914 |  |  | $ | 9,689 |  |  | $ | 6,107 |

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=bvs_BioVentusLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |